Vimta Labs Past Earnings Performance
Past criteria checks 2/6
Vimta Labs has been growing earnings at an average annual rate of 26.9%, while the Life Sciences industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 13% per year. Vimta Labs's return on equity is 13.9%, and it has net margins of 12.9%.
Key information
26.9%
Earnings growth rate
26.8%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 13.0% |
| Return on equity | 13.9% |
| Net Margin | 12.9% |
| Next Earnings Update | 18 May 2024 |
Recent past performance updates
Recent updates
Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost
Apr 26
It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)
Jan 06If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity
Jul 14Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00
Jun 03Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00
May 06A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)
Dec 07Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today
Nov 06Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00
Jun 02Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?
Dec 06Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Oct 27We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now
Jun 29Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?
Jun 19Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Mar 09Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 20Did You Miss Vimta Labs' (NSE:VIMTALABS) 87% Share Price Gain?
Dec 30Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?
Dec 09
Here's What We Learned About The CEO Pay At Vimta Labs Limited (NSE:VIMTALABS)
Nov 17Vimta Labs Limited's (NSE:VIMTALABS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Oct 21Here's Why Vimta Labs (NSE:VIMTALABS) Has A Meaningful Debt Burden
Sep 10Vimta Labs Limited's (NSE:VIMTALABS) Price Is Out Of Tune With Earnings
Aug 05Vimta Labs Limited's (NSE:VIMTALABS) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Jul 14Revenue & Expenses BreakdownBeta
How Vimta Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3,212 | 413 | 1,044 | 0 |
| 30 Sep 23 | 3,169 | 415 | 1,019 | 0 |
| 30 Jun 23 | 3,234 | 483 | 999 | 0 |
| 31 Mar 23 | 3,190 | 482 | 980 | 0 |
| 31 Dec 22 | 3,109 | 473 | 975 | 0 |
| 30 Sep 22 | 3,009 | 488 | 937 | 0 |
| 30 Jun 22 | 2,965 | 453 | 879 | 0 |
| 31 Mar 22 | 2,787 | 413 | 834 | 0 |
| 31 Dec 21 | 2,644 | 372 | 771 | 0 |
| 30 Sep 21 | 2,557 | 336 | 738 | 0 |
| 30 Jun 21 | 2,396 | 314 | 718 | 0 |
| 31 Mar 21 | 2,110 | 214 | 665 | 0 |
| 31 Dec 20 | 1,945 | 137 | 637 | 0 |
| 30 Sep 20 | 1,873 | 104 | 635 | 0 |
| 30 Jun 20 | 1,694 | 37 | 594 | 0 |
| 31 Mar 20 | 1,811 | 68 | 653 | 0 |
| 31 Dec 19 | 1,914 | 136 | 684 | 0 |
| 30 Sep 19 | 1,906 | 140 | 673 | 0 |
| 30 Jun 19 | 2,025 | 200 | 671 | 0 |
| 31 Mar 19 | 2,130 | 253 | 665 | 0 |
| 31 Dec 18 | 2,126 | 236 | 666 | 0 |
| 30 Sep 18 | 2,071 | 245 | 646 | 0 |
| 30 Jun 18 | 1,970 | 218 | 621 | 0 |
| 31 Mar 18 | 1,836 | 164 | 595 | 0 |
| 31 Dec 17 | 1,693 | 134 | 562 | 0 |
| 30 Sep 17 | 1,602 | 104 | 548 | 0 |
| 30 Jun 17 | 1,552 | 83 | 534 | 0 |
| 31 Mar 17 | 1,538 | 106 | 503 | 0 |
| 31 Dec 16 | 1,468 | 94 | 460 | 0 |
| 30 Sep 16 | 1,376 | 74 | 433 | 0 |
| 30 Jun 16 | 1,344 | 79 | 349 | 0 |
| 31 Mar 16 | 1,247 | 64 | 382 | 0 |
| 31 Dec 15 | 1,202 | 63 | 486 | 0 |
| 30 Sep 15 | 1,157 | 59 | 475 | 0 |
| 30 Jun 15 | 1,068 | 45 | 316 | 0 |
| 31 Mar 15 | 1,073 | 51 | 343 | 0 |
| 31 Dec 14 | 1,082 | 52 | 477 | 0 |
| 30 Sep 14 | 1,140 | 85 | 466 | 0 |
| 30 Jun 14 | 1,195 | 114 | 455 | 0 |
| 31 Mar 14 | 1,183 | 132 | 443 | 0 |
| 31 Dec 13 | 1,175 | 130 | 395 | 0 |
| 30 Sep 13 | 1,130 | 104 | 388 | 0 |
| 30 Jun 13 | 1,101 | 75 | 382 | 0 |
Quality Earnings: VIMTALABS has high quality earnings.
Growing Profit Margin: VIMTALABS's current net profit margins (12.9%) are lower than last year (15.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VIMTALABS's earnings have grown significantly by 26.9% per year over the past 5 years.
Accelerating Growth: VIMTALABS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VIMTALABS had negative earnings growth (-12.6%) over the past year, making it difficult to compare to the Life Sciences industry average (-1.4%).
Return on Equity
High ROE: VIMTALABS's Return on Equity (13.9%) is considered low.